AssetMark Inc’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
MC
WA
AssetMark Inc's RGEN Position: Q2 2026 in Review
AssetMark Inc reduced its Repligen (RGEN) stake by 70% in Q2 2026, selling an estimated $2.33K and leaving 8 shares worth $1.09K. The position accounts for ﹤0.01% of the portfolio, ranked #3130.
AssetMark Inc first reported a position in RGEN in Q4 2017 and has held it in 23 quarters since. The position peaked at $878K in Q3 2022. 481 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- AssetMark Inc held 8 shares of Repligen worth $1.09K as of Q2 2026.
- AssetMark Inc sold 19 Repligen shares in Q2 2026, an estimated $2.33K.
- Repligen made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #3130 holding.
- AssetMark Inc first reported a position in Repligen in Q4 2017 and has held it in 23 quarters since.
- AssetMark Inc's Repligen position peaked at $878K in Q3 2022.
- 481 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.